Cudraflavanone A, a flavonoid isolated from the root bark of Cudrania tricuspidata, inhibits vascular smooth muscle cell growth via an Akt-dependent pathway

Planta Medica

Volumn 73, Issue 11, 2007, Pages 1163-1168

  Han, Hyeong Jun ^a   Kim, Tack Joong ^a   Jin, Yong Ri ^a   Hong, Seong Su ^a   Hwang, Ji Hye ^a   Hwang, Bang Yeon ^a   Lee, Kwang Ho ^b   Park, Tae Kyu ^b   Yun, Yeo Pyo ^a  

^a Chungbuk National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Akt; Cudraflavanone A; Cudrania tricuspidata; Moraceae; Vascular smooth muscle cell

Indexed keywords

CUDRAFLAVANONE A; FLAVANOID; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOLIPASE C GAMMA; PLANT EXTRACT; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; THYMIDINE; UNCLASSIFIED DRUG;

ANGIOPLASTY; ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL COUNT; CELL CYCLE PROGRESSION; CELL GROWTH; CONCENTRATION RESPONSE; CUDRANIA TRICUSPIDATA; DRUG ISOLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GROWTH INHIBITION; MEDICINAL PLANT; NONHUMAN; PLAQUE FORMING CELL; RAT; RESTENOSIS; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; CELL PROLIFERATION; CELLS, CULTURED; FLAVANONES; FLAVONES; MORACEAE; MUSCLE, SMOOTH, VASCULAR; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PROTO-ONCOGENE PROTEINS C-AKT; RATS;

MACLURA TRICUSPIDATA; MORACEAE; RATTUS;

EID: 35348844058     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981584     Document Type: Article

References (22)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
2. Maresta A, Balducelli M, Cantini L, Casari A, Chioin R, Fabbri M et al. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica. Circulation 1994; 90: 2710-5.
3. Ko Y, Totzke G, Graack GH, Heidgen FJ, Meyer zu Brickwedde MK, Dusing R et al. Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells. J Hypertens 1993; 11: 1171-8.
4. Kumar MS, Owens GK. Combinatorial control of smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol 2003; 23: 737-47.
5. Kim TJ, Yun YP. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells. Vasc Pharmacol 2007; 46: 43-51.
6. Myllarniemi M, Frosen J, Calderon Ramirez LG, Buchdunger E, Lemstrom K, Hayry P. Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo. Cardiovasc Drugs Ther 1999; 13: 159-68.
7. Kim JH, Jin YR, Park BS, Kim TJ, Kim SY, Lim Y et al. Luteolin prevents PDGF-BB-induced proliferation of vascular smooth muscle cells by inhibition of PDGF beta-receptor phosphorylation. Biochem Pharmacol 2005; 69: 1715-21.
8. Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1998; 1378: F79-113.
9. Graf K, Xi XP, Yang D, Fleck E, Hsueh WA, Law RE. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension 1997; 29: 334-9.
10. Pyles JM, March KL, Franklin M, Mehdi K, Wilensky RL, Adam LP. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ Res 1997; 81: 904-10.
11. Seo WG, Pae HO, Oh GS, Chai KY, Yun YG, Kwon TO et al. Inhibitory effect of ethyl acetate fraction from Cudrania tricuspidata on the expression of nitric oxide synthase gene in RAW 264.7 macrophages stimulated with interferon-gamma and lipopolysaccharide. Gen Pharmacol 2000; 35: 21-8.
12. Lee BW, Lee JH, Lee ST, Lee HS, Lee WS, Jeong TS et al. Antioxidant and cytotoxic activities of xanthones from Cudrania tricuspidata. Bioorg Med Chem Lett 2005; 15: 5548-52.
13. An RB, Sohn DH, Kim YC. Hepatoprotective compounds of the roots of Cudrania tricuspidata on tacrine-induced cytotoxicity in Hep G2 cells. Biol Pharm Bull 2006; 29: 838-40.
14. Park KH, Park YD, Han JM, Im KR, Lee BW, Jeong IY et al. Anti-atherosclerotic and anti-inflammatory activities of catecholic xanthones and flavonoids isolated from Cudrania tricuspidata. Bioorg Med Chem Lett 2006; 16: 5580-3.
15. Lee BW, Gal SW, Park KM, Park KH. Cytotoxic xanthones from Cudrania tricuspidata. J Nat Prod 2005; 68: 456-8.
16. Zou YS, Hou AJ, Zhu GF. Isoprenylated xanthones and flavonoids from Cudrania tricuspidata. Chem Biodivers 2005; 2: 131-8.
17. Fujimoto T, Nomura T. Components of root bark of Cudrania tricuspidata; 3. Isolation and structure studies on the flavonoids. Planta Med 1985; 51: 190-3.
18. Kim TJ, Zhang YH, Kim Y, Lee CK, Lee MK, Hong JT et al. Effects of apigenin on the serum- and platelet-derived growth factor-BB-induced proliferation of rat aortic vascular smooth muscle cells. Planta Med 2002; 68: 605-9.
19. Chamley-Campbell J, Campbell GR, Groschel-Stewart U, Burnstock G. FITC-labelled antibody staining of tropomyosin-containing fibrils in smooth, cardiac and skeletal muscle cells, prefusion myoblasts, fibroblasts, endothelial cells and 3T3 cells in culture. Cell Tissue Res 1977; 183: 153-66.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
21. Higaki M, Shimokado K. Phosphatidylinositol 3-kinase is required for growth factor-induced amino acid uptake by vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19: 2127-32.
22. Downward J. Signal transduction. New exchange, new target. Nature 1998; 396: 416-7.